Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,144 | 67,941 | 58,925 | 83,634 | 250,728 |
| Marketable Securities | 330,171 | 326,999 | 384,752 | 434,970 | 160,915 |
| Receivables | 8,032 | 7,125 | 13,851 | 10,259 | 19,064 |
| TOTAL | $448,445 | $487,397 | $542,425 | $588,435 | $471,171 |
| Non-Current Assets | |||||
| PPE Net | 17,453 | 17,579 | 18,111 | 10,930 | 11,348 |
| Investments And Advances | 3,907 | 3,887 | 3,909 | 3,630 | 4,895 |
| Intangibles | 13,140 | 13,267 | 13,393 | 13,523 | 13,660 |
| Other Non-Current Assets | 12,997 | 13,633 | 14,004 | 38,345 | 38,699 |
| TOTAL | $47,497 | $48,366 | $49,418 | $66,429 | $68,602 |
| Total Assets | $495,942 | $535,763 | $591,842 | $654,863 | $539,773 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 48,193 | 29,147 | 31,869 | 26,743 | 21,847 |
| Accrued Expenses | 10,326 | 13,619 | 10,416 | 7,371 | 9,950 |
| TOTAL | $65,742 | $51,376 | $51,749 | $41,540 | $41,706 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 4,516 |
| Deferred Revenues | 4,619 | 6,074 | 7,000 | 5,030 | 7,579 |
| Other Non-Current Liabilities | 30,434 | 30,677 | 31,398 | 31,573 | 32,261 |
| TOTAL | $30,530 | $30,814 | $31,539 | $31,718 | $36,926 |
| Total Liabilities | $96,272 | $82,190 | $83,288 | $73,257 | $78,632 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,110 | 17,525 | 17,523 | 17,443 | 17,296 |
| Common Shares | 217 | 210 | 210 | 209 | 187 |
| Retained earnings | -1,209,855 | -1,102,908 | -1,042,739 | -960,599 | -906,197 |
| Other shareholders' equity | -283 | -258 | -265 | -265 | -256 |
| TOTAL | $399,669 | $453,572 | $508,554 | $581,606 | $461,141 |
| Total Liabilities And Equity | $495,942 | $535,763 | $591,842 | $654,863 | $539,772 |